McIlrath & Eck’s Encompass Health EHC Stock Holding History

McIlrath & Eck’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37	Closed	-$3.42K	–	956
2024 Q4	$3.42K	Hold	37	–	–	﹤0.01%	810
2024 Q3	$3.58K	Hold	37	–	–	﹤0.01%	801
2024 Q2	$3.17K	Hold	37	–	–	﹤0.01%	778
2024 Q1	$3.06K	Hold	37	–	–	﹤0.01%	788
2023 Q4	$2.47K	Hold	37	–	–	﹤0.01%	785
2023 Q3	$2.48K	Hold	37	–	–	﹤0.01%	751
2023 Q2	$2.5K	Hold	37	–	–	﹤0.01%	767
2023 Q1	$2K	Hold	37	–	–	﹤0.01%	778
2022 Q4	$2.21K	Hold	37	–	–	﹤0.01%	741
2022 Q3	$2K	Sell	37 -10	-21%	-$500	﹤0.01%	754
2022 Q2	$2K	Hold	47	–	–	﹤0.01%	735
2022 Q1	$3K	Hold	47	–	–	﹤0.01%	693
2021 Q4	$2K	Hold	47	–	–	﹤0.01%	715
2021 Q3	$3K	Hold	47	–	–	﹤0.01%	688
2021 Q2	$3K	Hold	47	–	–	﹤0.01%	686
2021 Q1	$3K	Hold	47	–	–	﹤0.01%	651
2020 Q4	$3K	Hold	47	–	–	﹤0.01%	585
2020 Q3	$2K	Hold	47	–	–	﹤0.01%	586
2020 Q2	$2K	Buy	+47	New	+$2.54K	﹤0.01%	587

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

McIlrath & Eck's EHC Position: Q1 2025 in Review

McIlrath & Eck sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 37 shares — an estimated $3.42K sold.

McIlrath & Eck first reported a position in EHC in Q2 2020 and held it in 19 quarters. The position peaked at $3.58K in Q3 2024. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

McIlrath & Eck reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
McIlrath & Eck sold 37 Encompass Health shares in Q1 2025, an estimated $3.42K.
McIlrath & Eck first reported a position in Encompass Health in Q2 2020 and held it in 19 quarters.
McIlrath & Eck's Encompass Health position peaked at $3.58K in Q3 2024.
537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on McIlrath & Eck's 13F filing for Q1 2025, filed 16 May 2025.